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ABSTRACT
Background No clear synthesis of evidence examining
household and area-level social determinants of
multimorbidity exists. This study aimed to systematically
review the existing literature on associations between
household and area-level social determinants of health
(SDoH) and multimorbidity prevalence or incidence in the
general population.
Methods Six databases (MedLine, EMBASE, PsychINFO,
Web of Science, CINAHL Plus and Scopus) were searched.
The search was limited to peer-reviewed studies
conducted in high-income countries and published in
English between 2010 and 2019. A second reviewer
screened all titles with abstracts and a subset of full texts.
Study quality was assessed and protocol pre-registered
(CRD42019135281).
Results 41 studies spanning North America, Europe and
Australasia were included. Household income and area-
level deprivation were the most explored with fairly
consistent findings. The odds of multimorbidity were up to
4.4 times higher for participants with the lowest level of
income compared with the highest level. Those living in the
most deprived areas had the highest prevalence or
incidence of multimorbidity (pooled OR 1.42, 95% CI 1.41
to 1.42). Associations between deprivation and
multimorbidity differed by age and multimorbidity type.
Findings from the few studies investigating household
tenure, household composition and area-level rurality were
mixed and contradictory; homeownership and rurality were
associated with increased and decreased multimorbidity,
while living alone was found to be associated with a higher
risk of multimorbidity and not associated.
Conclusion Improving our understanding of broader
social determinants of multimorbidity—particularly at the
household level—could help inform strategies to tackle
multimorbidity.
INTRODUCTION
Multimorbidity is one of the greatest challenges for
health and care systems worldwide.1 Broadly
defined as the co-occurrence of multiple chronic
conditions within the same individual,2 multimor-
bidity is now the norm internationally, not the
exception.3 Indeed, approximately one-third of UK
primary care patients has two or more long-term
conditions.4 This is projected to increase dramati-
cally over the coming decade.5
Multimorbidity challenges health and care sys-
tems because care must, by definition, cross organi-
sational and sectoral boundaries.6 7 This requires
a radical shift in approach from a fragmented med-
ical model of illness, centred on specific disorders,
to a more holistic view of health. There are also calls
for approaches focused on preventing multimorbid-
ity or curtailing multimorbidity progression that
could minimise the future burden on the system.1
Such shifts in approach require an understanding of
the broader factors associated with multimorbidity.
While multimorbidity is often framed as a health
issue, it is greatly influenced in extent and nature by
social determinants of health (SDoH). There are
multiple conceptualisations of SDoH; nevertheless,
a hierarchical division of individual, household and
area-level social factors is common to many.8–10
Individual social determinants (SD) of multimorbid-
ity are well established—prevalence is greater
among ethnic minorities and individuals with
fewer educational qualifications.11–14 However,
understanding of household and area-level SD is
limited with most primary research focusing on
area-level deprivation indices. At present, no clear
synthesis of evidence examining household and
area-level SD of multimorbidity exists.11 15–18
This review aimed to systematically identify, criti-
cally appraise and synthesise the existing literature
on associations between household and area-level
SDoH and multimorbidity prevalence or incidence
in general populations of high-income countries
(HICs). We also aimed to investigate how associa-
tions differ with age, gender and ethnicity. Better
understanding of SD of multimorbidity could inform
equitable prevention and intervention strategies.
METHODS
This review was conducted following PRISMA
guidelines19 and the protocol prospectively regis-
tered with PROSPERO (CRD42019135281).
Eligibility criteria for inclusion
Studies were included if in English, conducted in HICs
and published between 1 January 2010 and
10 January 2019. The former date restriction coincides
with the publication of The Marmot Report, which
raised the profile of SDoH in England.20 We excluded
studies conducted solely with institutionalised indivi-
duals as SDofmultimorbiditymay differ between insti-
tutional and community settings.21Weexcluded studies
conducted with solely young people (<18 years) as
prevalence is low for this group22 23 (table 1).
Search strategy
The following six databases were searched:
MedLine, EMBASE, PsychINFO, Web of Science,
CINAHL Plus and Scopus. Terms relating to multi-
morbidity, specific SDoH and household or area






















were combined using Boolean language. We drew on published
frameworks and previous literature to develop SDoH search
terms.8–10 24–27 Terms were initially developed in MedLine
(online appendix 1) and adapted for each database. After the
initial search, we added the MeSH term ‘comorbidity’ into our
MedLine search to examine if any studies had been missed
through excluding the term ‘comorbidity’ and its linguistic varia-
tions. A combination of forward and backward citation search-
ing, and searching citations of relevant reviews, was used to
identify further studies.
EI and SL independently screened titles and abstracts of all
records from database searches. A third reviewer independently
screened 100 randomly selected records. EI screened all full texts
and SL a subset (20%). All relevant data were extracted by EI
using a pre-piloted form including study characteristics, defini-
tions of exposures and outcomes, and findings (online appendix
2). The authors were contacted if data extractionwas incomplete.
Inter-rater reliability was calculated using Kappa statistics and
differences resolved by discussion.
Quality assessment
Study quality was assessed within four domains: selection bias,
information bias for exposure and outcome, and confounding
(online appendix 3). Non-interventional studies are rarely at
low overall risk of bias and reporting by domain allows compar-
ison of the main sources of bias across studies.28 Each study was
assigned high, medium, low or unclear ratings for each domain, to
separate study quality from reporting quality.29 30 Criteria were
specific to the study and informed by existing checklists.28 31 Risk
of selection bias was assessed by comparing sample demographics
to census data when possible. Studies where risk of bias was high
across two or more domains were deemed low quality. Studies
where risk of bias was mixed or medium across all domains were
deemed moderate. Studies with a low risk of bias across two or
more categories, with no high risk of bias across any domains,
were deemed high quality. EI completed all assessments and SL
a random subset (20%). Quality assessments were used to provide
insight into the overall quality of evidence in this field, rather than
to exclude or rank studies. Assessments were also used to explore
any associations between study results and quality assessments.
Data synthesis
Findings were narratively synthesised given the diverse exposures,
outcomes and study methodologies. Studies were too heteroge-
neous to allow a meta-analysis of findings. Available data were
pooled for studies investigating area-level deprivation to calculate
overall multimorbidity prevalence in deprivation quintiles.
RESULTS
Study selection and characteristics
Forty-one studieswere included (figure 1). Inter-rater reliabilitywas
good for title and abstract screening (κ=0.71), and full-text
(κ=0.77).32
Online appendix 4 details key study characteristics. Studies
were conducted in a range of countries, the most common
being Canada, England and Spain. Sample sizes ranged from
232 to 13 581 191. Twenty-five studies included participants
from across the life-course, while nine focused on adults aged
50 and over. Household SDoH included measures of household
income, tenure and composition, self-reported by participants in
all studies. Area-level SDoH includedmeasures of socioeconomic
deprivation and rurality, the former measured using validated
indices (16/17 studies) and polling data (one study).
Defining and measuring multimorbidity
Most studies (34/41) defined multimorbidity as two or more
conditions taken from a pre-specified list of ‘long-term’ or
‘chronic’ conditions. Eight also used three or more conditions
as the cut-off and seven studies used a count of conditions as one
outcome. Six studies examined if associations differed with mul-
timorbidity type: multimorbidity specifically comprising physical
and mental health conditions (physical–mental multimorbidity),
physical conditions (physical-only multimorbidity) and mental
health conditions (mental-only multimorbidity).
Across the 41 studies, the number of conditions included on
the pre-specified list ranged from five conditions to 146 diagnos-
tic clusters defined using O’Halloran’s criteria for chronicity.33
Thirty-six of 41 studies included a mix of chronic physical and
mental health conditions,4 22 34–67 while four included physical
conditions only.68–71 One study was unclear about the conditions
included.72 To determine the presence of conditions, 17 studies
used self-reported participant data, 17 screened electronic health
records (EHRs), and six used a combination of the two. One
study did not detail how they identified multimorbidity
presence70 (online appendix 4).
Study results
Household income (n=15): Thirteen studies consistently found
multimorbidity prevalence or incidence was markedly and nega-
tively associated with household income and, of all SDoH inves-
tigated, associations were consistently strongest for household
Table 1 Inclusion and exclusion criteria
Inclusion Exclusion
Population Participants from the general
population and assessed for the
presence of multiple chronic
conditions (multimorbidity).
Participants initially selected
based on the presence of index
diseases (ie, studies of
comorbidity). Participants from
solely institutionalised care
settings (eg, nursing homes).
Participants solely young people
(age <18 years).
Exposure Study exposure(s) included at least
one household or area-level SDoH
that aligns with factors from the
World Health Organisation (WHO)
Commission on SDoH (CSDH)
Framework9 and the idea that
SDoH are ‘causes of the causes’ of
ill-health20 (eg, household income
or area-level deprivation).
Study exposure(s) include
individual SDoH only (eg,
ethnicity). Study exposure(s) are
direct “causes” of ill-health, such
as health behaviours (eg,
smoking), or are factors
associated with the health system
itself (eg, access to services).
Comparator Study reports comparator group(s)
for SDoH exposure(s) (eg, what is
the prevalence of multimorbidity
for those in the lowest vs the
highest household income
groups).
Study does not report
a comparator group for SDoH
exposure(s).
Outcome Assess multimorbidity burden
(prevalence or incidence studies).
Assignment to multimorbidity
patterns or trajectories. Measures
of multimorbidity severity (eg,
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income.39–41 43 48 53 60–62 65 66 68 69 Higher quality studies
reported comparatively small estimated effect sizes, for exam-
ple, Agborsangaya et al reported that an annual household
income<$30 000 CADwas associated with a 2.39-fold increase
in multimorbidity prevalence (95% CI 1.72 to 3.33) compared
with ≥$100 000 CAD, after multiple adjustments.62 In con-
trast, Roberts et al—a lower quality study—reported chances of
multimorbidity 4.4 times higher for participants with the lowest
level of income compared with the highest in multivariate ana-
lyses (OR 4.4, 95% CI 3.6 to 5.5).53
Two further studies—of low andmoderate quality, respectively—
examined problems managing household income and reported
mixed results.52 59 Verest et al reported thosewith ‘lots of problems’
were over 5 times likely to have multimorbidity compared with
those with ‘no problems’ (OR 5.36, 95% CI 4.88 to 5.88).
Inequalities were similar by gender and ethnicity.59 In contrast,
Prazeres et al found no evidence of an association when screening
EHRs.52
See table 2 for key results and quality assessments for these 13
studies, and online appendix 4 for more details on study
characteristics.
Household composition (n=7): Four studies measured house-
hold composition as living alone vs cohabiting and three studies
measured it as living alone, living with various family members or
living in other situations (including care homes).
Four cohort studies of older adults (50–84) reported mixed
findings on the risk of living alone vs cohabiting.37 45 47 70 Two
high-quality studies found living alone increased chances of mul-
timorbidity vs living with others,37 70 for example, Cantarero-
Prieto et al found living alone increased chances of multimorbid-
ity by 20% (OR 1.20, 95% CI 1.04 to 1.39, p<0.05).70 Whereas
two other studies—high and moderate quality—found no evi-
dence, living alone was associated with multimorbidity
incidence.45 47 Differences in study characteristics such as meth-
ods of ascertaining multimorbidity presence could not explain
these mixed findings.
Of the three studies with alternative measures of composition,
onemoderate-quality cross-sectional study found that odds ofmulti-
morbidity were over 2 times greater if not living with children vs
living with children (OR 2.11, 95% CI 1.60 to 2.78; adjusted for
age).61 Two further moderate-quality studies (one included solely
older adults) found no evidence of any associations with multimor-
bidity when living alone was compared with living as a couple, with
family/others or living in situations such as care homes.52 60
See table 3 for key results and quality assessments for these
seven studies, and online appendix 4 for more details on study
characteristics.
Household tenure (n=4): Findings from studies investigating
tenure were mixed and hard to compare given different reference
groups and comparators; two studies compared homeowners and
non-homeowners, one compared renters with homeowners and
one compared social housing residents with homeowners, private
renters and subsidised housing residents.60 65 66 69 All four were of
moderate quality. Lebenbaum et al found the odds of multimorbid-
ity decreased by 18% for homeowners compared with non-
homeowners (OR0.82, 95%CI 0.78 to 0.87, p<0.001),66 whereas
Johnson-Lawrence et al reported 19% higher odds for renters vs
homeowners (OR 1.19, 95% CI 1.15 to 1.24).69 In contrast,
Schäfer et al—the only cohort study—found no evidence of an
association between homeownership and count of conditions in
older adults.60 One study found that, compared with social housing
residents, homeowners and private renters had 17% (OR 1.17,
95% CI 1.11 to 1.24, p=0.003) and 19% (OR 1.19, 95% CI 1.09
to 1.29, p=0.041) higher odds of multimorbidity, respectively.65
Differences in study characteristics could not explain mixed
findings.
Figure 1 PRISMA flow diagram.






















Table 2 Key results and quality assessments for studies investigating household income (n=13)
First author

















<$30 k vs ≥$100 k CAD
Age, sex, education, living
with children






<$30 k vs ≥$100 k CAD
Age, sex, education,
obesity
















Monthly income ≤$2 k vs
>$4 k USD










region, marital status, last
doctor visit, employment,
home ownership






Lowest income† tertile vs
highest





M M M L
Ki(2017)40 Yes OR 3.48*
(3.20–3.78)
“Poor” (less than half the
median annual household
income†) vs “non-poor”
No adjustment U H M H

















L M H L




Income >$70 k vs
<$20 k CAD






Lowest income tertile vs
highest







over’ vs ‘Not enough
monthly income to make
ends meet’
























Change per unit on
income† scale (one
unit=one of steps: €400 to
€1100 to €3000 to €8100










managing money vs “no
problems”
No adjustment H H M H
*OR calculated from data reported in paper.
†Income equivalised to account for number and/or age of residents in household.
‡Based on self-reported health data. Findings consistent across hospital and medication health data.
§Multimorbidity defined as ≥2 chronic conditions.
¶H, High; M, Medium; L, Low; U, Unclear.
**Inequalities greater for ages 25–44.
††Inequalities greater for women and similar by ethnicity group.






















Table 3 Key results and quality assessments for studies investigating household composition (n=7), household tenure (n=4) and household rurality
(n=7), structured per social determinant
Risk of Bias§













vs not living with
children
Living with adults vs
not living with adults
Age, sex, education and
household income
H M M L
Cantarero-Prieto
(2018)70
Yes OR 1.20 (1.04–1.39, p<0.05) Living alone vs
cohabits
Unclear U U M U
Henchoz (2019)37 Yes OR 1.40* (1.21–1.61) Living alone vs
cohabits
No adjustment U M M M
Melis (2014)45 No OR 1.34 (0.60–3.01) Living alone vs
cohabits
No adjustment U M L H
Mounce (2018)47 No HR 0.93 (0.71–1.21, p=0.580) Living alone vs
cohabits




detachment and locus of
control
U M M L
Prazeres (2015)52 No OR 1.4§ (0.9–2.3, p=0.182)
OR 1.0§ (0.6–1.7, p=0.985)
OR 1.3§ (0.7–2.6, p=0.410)











H M L L






Living at home with
spouse vs home
alone
Living at home with
family members or
others vs home alone
Living in assisted
living or retirement





H M L U
Household tenure
Chung(2015)65 Yes OR 1.17 (1.11–1.24, p=0.003)
OR 1.19 (1.09–1.29, p=0.041)











H M M L
Johnson-Lawrence
(2017)69




region, marital status, last
doctor visit, employment,
household income
U M H L
Lebenbaum
(2018)66
Yes OR 0.82 (0.78–0.87, p<0.001) Homeowners vs non-
homeowners





L M H L








H M L U
Continued






















See table 3 for key results and quality assessments for these four
studies, and online appendix 4 for more details on study
characteristics.
Household determinants in childhood (n=5): Two studies
examined associations between paternal social class at birth and
multimorbidity. Findings were mixed. One higher quality study
from Johnston et al found lower paternal social class at birth was
associated with increased multimorbidity in middle age.72
Conversely, one study of lower quality reported no association.38
Two studies investigated associations between self-reported
childhood financial hardships and multimorbidity and, again,
findings were mixed.37 71 One higher quality study found no
evidence of an association,37 whereas one fairly low-quality
study found evidence that the number of chronic conditions for
those reporting hardships was 1.19 times that of those not report-
ing hardships (95% CI 1.07 to 1.32, p<0.001).71
One further study, moderate in quality, found the odds of multi-
morbidity increased by 40% among those who had experienced
household dysfunction during childhood (eg, parental divorce) in
multivariate analyses (OR 1.4, 95% CI 1.1 to 1.7, p<0.05).56
Household primary language and education (n=2):One mod-
erate-quality Australian study found associations between living
in a household where English was the first language and multi-
morbidity prevalence differed depending on the source of health
information.43 One lower quality study found higher odds of
multimorbidity for participants living in households where no
residents had completed high school compared with post-
secondary school education (OR 1.8, 95% CI 1.6 to 2.1, adjust-
ing for age and sex).53
Household rurality (n=7): Studies that investigated associations
between residing in rural vs non-rural/urban areas and multimor-
bidity reported mixed results.36 43 52–54 66 70 Only two studies
were high quality and provided clear rurality definitions; these
both suggested odds of multimorbidity decreased with increased
rurality.36 54 Conversely, two studies, one low53 and onemoderate
quality43 reported greater odds of multimorbidity with increased
rurality. Three further studies found no evidence of any
association.52 66 70 Aside from study quality, differences in study
characteristics could not explain these mixed findings.
See table 3 for key results and quality assessments for these
seven studies, and online appendix 4 for more details on study
characteristics.
Area-level socioeconomic deprivation (n=17): Studies that
investigated how the socioeconomic situation of participants’
residential area was associated with multimorbidity prevalence
or incidence showed fairly consistent findings.4 22 34 35 39 42 44 46
49–51 54 55 57 63 64 67 In general, multimorbidity was higher for
participants residing in areas of greater deprivation than those
Table 3 Continued
Risk of Bias§








No OR 0.92 (0.93–1.03, p>0.1) Living in rural vs non-
rural areas
Unclear U U M U
Foguet-Boreu
(2014)36






Unadjusted U L L U
Lebenbaum
(2018)66
No OR 0.98 (0.93–1.02, p=0.323) Rural vs non-rural
areas





L M H L
Lujic (2017)43 Yes OR 1.14† (1.03–1.26) Living in remote/very
remote areas (vs
major cities)
Age and sex H M M M
Prazeres (2015)52 No OR 1.0‡ (0.8–1.3, p=0.746) Living in rural vs
urban areas




H M L L








H M H M




Age-sex standardised L L L M
*OR calculated from data reported in paper.
†Based on self-reported health data. Findings consistent across hospital and medication health data.
‡Multimorbidity defined as ≥2 chronic conditions.
§H, High; M, Medium; L, Low; U, Unclear.
¶Associations greater for 65+.
**Inequalities similar with gender and greater≥45 years.






















living in more affluent areas. Odds of multimorbidity prevalence
were 42% higher for participants residing in the most vs the least
deprived areas when available data were pooled (OR 1.42, 95%
CI 1.41 to 1.42; figure 2). Differences in study quality could not
explain differences in reported effect sizes across studies.
Four studies found inequalities with area-level deprivation were
greater among women than men.35 49–51 Only one low-quality
study investigated how associations differed by ethnicity, and they
found that inequalities were greater for Pacific vs Maori New
Zealand residents.67
Trust in neighbours (n=1):One fairly low-quality study found
that participants who somewhat distrusted their neighbours had
increased risk of developingmultimorbidity within 11 years com-
pared with those who strongly disagreed with the statement ‘One
cannot trust each other here’ (RR 1.13, 95% CI 1.03 to 1.23).58
Older adult populations and older adult sub-group analyses
(n=21): Nine studies included samples of adults solely aged 50
and over.37 38 45–47 50 60 70 71 Five of these examined associations
between household composition and multimorbidity (results
described above).37 45 47 60 70 There were no differences in results
for studies with older adults only compared with studies that
included younger adults.
Thirteen studies examined whether associations differed with
subgroups of age.4 22 35 36 42 44 46 50 51 53 57 61 63 Estimated effect
sizes were greater in younger comparedwith older adults for house-
hold income—for example, Roberts et al reported greater odds of
multimorbidity amongst 35–49 year olds compared with over 65s
for thosewith the lowest income vs the highest (OR7.5, 95%CI 4.0
to 13.7 vs OR 2.5, 95% CI 1.8 to 3.5, respectively; see table 2).53
However, Agborsangaya et al (2012) found that associations
between multimorbidity and not living with children (vs living
with children) were greater for those ≥65 years of age compared
with those 25–44, adjusting for sex and household income (OR
8.45, 95% CI 2.02 to 35.41 vs OR 2.00, 95% CI 1.29 to 3.02,
respectively; see table 3).61 Ten studies found that differences in
multimorbidity prevalence with area deprivation reduced in older
age.4 22 35 42 44 46 50 51 57 63 Inequalities across deprivation
categories were greater in middle age for general
multimorbidity,4 22 35 42 44 51 57 63 in younger age groups for physi-
cal–mental multimorbidity4 44 and mental-only multimorbidity,44
and in older age for physical-onlymultimorbidity.44One study exam-
ining household rurality reported data showing similar associations in
older vs young groups36 (see table 3).
Online appendix 2 outlines our full data extraction table for all
41 studies.
DISCUSSION
This is the first study to systematically review and appraise exist-
ing literature on associations between household and area-level
SDoH and multimorbidity. Household income and area-level
deprivation were the most explored SDs, and findings for these
were fairly consistent; odds of multimorbidity were up to 4.4
times higher for those within the lowest level of household
income (vs the highest), and prevalence was 1.4 times higher in
the most vs the least deprived areas. Other household and area-
level SDoH have been underexplored.
Possible explanations for our findings
Previous research has proposed that household factors are often
overlooked in studies exploring SDoH, despite households (or
families) influencing physical and mental health through various
material and psychosocial factors.73–75
In this review, we identified seven studies that investigated
household composition and four that investigated household
tenure. Composition studies presented mixed results; living
alone was associated with increased multimorbidity in two
studies and not associated in four. These studies included
different reference groups and comparators, making them
hard to compare. For example, ill-health greatly drives care
home admissions76 and therefore comparing ‘living alone’
with either ‘not living alone’ or ‘living in a care home’
would likely be comparing groups in different health, leading
to differential associations between household composition
Figure 2 Multimorbidity prevalence with quintiles of area-level deprivation (1=least deprived and 5=most deprived). Calculations conducted by
authors and based on available and relevant pooled data from N=7 out of 17 studies.






















and multimorbidity. One further study found living with chil-
dren (vs not) was associated with increased chances of multi-
morbidity, and this effect was greater for over 65s. Chronic
illness may give rise to older individuals residing with family
and may lead younger individuals unable to (or decide not to)
have children. Interestingly, none of the included studies
examining household composition adjusted for care provi-
sion, which can differ considerably for those living with
a partner, family or alone77 and could plausibly influence
the relationship between composition and multimorbidity.
Further research should gather data on care provision and
adjust accordingly. Unpicking whether social circumstances
drive multimorbidity, or vice versa, also requires better
designed longitudinal studies. This could aid the targeting of
resources for prevention.
Studies investigating household tenure reported contradicting
results; homeownership was associated with both increased and
decreased chances of multimorbidity. Comparing these results
was, again, complicated by different reference groups and com-
parators; however, study contexts may be more pertinent here.
These studies were conducted in Hong Kong, Canada, USA and
Germany. The degree of homeownership, and supply and condi-
tions of social housing, may vary across these locations, for
example, approximately 45% of the Hong Kong population
lived in public housing in 2019 compared with 10% of the
German population in 2017.78 79 This, plus other social circum-
stances, could profoundly influence the status and stigma asso-
ciated with owning, renting, or residing in social housing across
geographies and over time, differentially impacting health and
associations between tenure and multimorbidity.80–82
A minority of studies examined whether associations differed
by age, gender or ethnicity. Findings suggest women experience
greater inequality in multimorbidity prevalence with area-level
deprivation, in line with research highlighting an increase in life
expectancy inequality for UK women.83 Prevalence with area-
level deprivation was also greater for younger populations for
physical–mental multimorbidity, unsurprising given the consis-
tently high prevalence of mental ill-health among young,
deprived communities.84 85 This, however, suggests that studies
excluding mental health conditions from multimorbidity defini-
tions or specifying multimorbidity as specifically crossing physi-
cal and mental health may report different associations than
studies not. Future research should consider physical and mental
dimensions of multimorbidity and examine whether associations
differ by key demographics. Further avenues for future research
should also examine the main explanatory factors, for example,
whether individual socioeconomic factors (such as education) or
behavioural factors (such as tobacco use) confound or explain
any observed associations. This could also aid the development of
tailored prevention and intervention strategies.
Lack of consensus around a multimorbidity definition is
a consistently raised issue.86 In this review, most studies defined
multimorbidity as two or more chronic conditions (the most used
definition in the literature86); however, several also used a cut-off
point of three or more or a count of conditions. To ascertain the
presence of multimorbidity, the included studies used either self-
reported data, data from EHRs or a combination of the two. This
hampered effective comparisons of study findings, yet we found
no evidence suggesting differences in findings could be explained
by differences in multimorbidity definitions or measurement
methods. There was also no variation in determinants of multi-
morbidity by measurement methods used. Consistent definitions
of multimorbidity and consistent methods for ascertaining its
presence are needed to improve the comparability of findings.
Strengths and limitations of this review
Strengths of this paper include the systematic inclusion of house-
hold SDoH, which has captured studies missed by previous
reviews,11 15–18 and the careful assessment of each study for
risk of four dimensions of bias using pre-specified criteria tailored
to the study. Limitations include that we excluded the term
‘comorbidity’ and its linguistic variations from our search despite
it being used interchangeably with ‘multimorbidity’.87 While this
may have missed some relevant literature, a subsequent ad hoc
search in MedLine, that included this term, did not identify any
additional, relevant hits. A large proportion of our included
studies were also identified via citation searching. We believe
that this is an intrinsic issue when conducting these types of
reviews; in the literature, SDoH are referred to by the determi-
nant of interest (eg, ‘rurality’) and search strategies need to pre-
specify terms to search for these, potentially missing relevant
studies. We also restricted our search to English-language pub-
lications and excluded studies conducted in low- and middle-
income countries (LMICs) as the socioeconomic gradient in mul-
timorbidity is reversed in LMICs.88
Implications for policy, research and practice
Household determinants of multimorbidity other than income
are often overlooked. Given the comparatively large effect sizes
for household compared with area-level SDoH, our study sug-
gests that strategies to tackle multimorbidity should consider
household-level factors. There is also a need for additional stu-
dies in different geographical contexts to gain a better under-
standing of the role of household SDoH on multimorbidity.
Policies aimed at reducing social inequalities could be important
components of strategies to tackle multimorbidity.
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What is already known on this subject
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